A detailed history of Clean Yield Group transactions in Novartis Ag stock. As of the latest transaction made, Clean Yield Group holds 374 shares of NVS stock, worth $37,063. This represents 0.01% of its overall portfolio holdings.

Number of Shares
374
Holding current value
$37,063
% of portfolio
0.01%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 07, 2024

BUY
$106.13 - $120.89 $39,692 - $45,212
374 New
374 $43,000
Q4 2020

Jan 26, 2021

SELL
$78.07 - $94.43 $2,029 - $2,455
-26 Closed
0 $0
Q3 2020

Oct 16, 2020

BUY
$82.14 - $91.0 $2,135 - $2,366
26 New
26 $2,000
Q1 2020

Apr 20, 2020

SELL
$70.67 - $99.01 $777 - $1,089
-11 Closed
0 $0
Q4 2019

Jan 17, 2020

SELL
$84.35 - $95.37 $19,653 - $22,221
-233 Reduced 95.49%
11 $1,000
Q3 2019

Oct 23, 2019

BUY
$85.54 - $94.26 $7,270 - $8,012
85 Added 53.46%
244 $21,000
Q2 2019

Jul 22, 2019

BUY
$75.4 - $92.8 $11,988 - $14,755
159 New
159 $15,000

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $213B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Clean Yield Group Portfolio

Follow Clean Yield Group and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Clean Yield Group, based on Form 13F filings with the SEC.

News

Stay updated on Clean Yield Group with notifications on news.